Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J J Foley

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1995
SB 209247, a high affinity LTB4 receptor antagonist demonstrating potent antiinflammatory activityH M Sarau, J J Foley, D B Schmidt, et al.
Journal of Medicinal Chemistry|September 13, 1996
(E)-3-[6-[[(2,6-dichlorophenyl)thio]methyl]-3-(2-phenylethoxy)-2- pyridinyl]-2-propenoic acid: a high-affinity leukotriene B4 receptor antagonist with oral antiinflammatory activityR A Daines, P A Chambers, J J Foley, et al.
Molecular Pharmacology|August 23, 2000
Evidence that the proposed novel human "neurokinin-4" receptor is pharmacologically similar to the human neurokinin-3 receptor but is not of human originH M Sarau, J L Mooney, D B Schmidt, et al.
Journal of Medicinal Chemistry|September 30, 1994
(E)-3-[[[[6-(2-carboxyethenyl)-5-[[8-(4- methoxyphenyl)octyl]oxy]-2-pyridinyl]-methyl]thio]methyl]benzoic acid and related compounds: high affinity leukotriene B4 receptor antagonistsR A Daines, P A Chambers, D S Eggleston, et al.
Nano Letters|December 15, 2016
Ultraconfined Plasmonic Hotspots Inside Graphene NanobubblesZ Fei, J J Foley, W Gannett, et al.
Journal of Medicinal Chemistry|September 3, 1993
(E)-3-[[[[6-(2-carboxyethenyl)-5-[[8-(4- methoxyphenyl)octyl]oxy]-2-pyridinyl]-methyl]thio]methyl]benzoic acid: a novel high-affinity leukotriene B4 receptor antagonistR A Daines, P A Chambers, I Pendrak, et al.
The Journal of Biological Chemistry|August 23, 1996
Molecular cloning and characterization of the human anaphylatoxin C3a receptorR S Ames, Y Li, H M Sarau, et al.
Molecular and Chemical Neuropathology|January 1, 1995
Time-related changes in myeloperoxidase activity and leukotriene B4 receptor binding reflect leukocyte influx in cerebral focal strokeF C Barone, L M Hillegass, M N Tzimas, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 2, 1998
Human anaphylatoxin C4a is a potent agonist of the guinea pig but not the human C3a receptorS Lienenklaus, R S Ames, M A Tornetta, et al.
Journal of Medicinal Chemistry|June 7, 1996
2-Phenyl-4-quinolinecarboxamides: a novel class of potent and selective non-peptide competitive antagonists for the human neurokinin-3 receptorG A Giardina, H M Sarau, C Farina, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1995
SB 209247, a high affinity LTB4 receptor antagonist demonstrating potent antiinflammatory activityH M Sarau, J J Foley, D B Schmidt, et al.
Journal of Medicinal Chemistry|September 13, 1996
(E)-3-[6-[[(2,6-dichlorophenyl)thio]methyl]-3-(2-phenylethoxy)-2- pyridinyl]-2-propenoic acid: a high-affinity leukotriene B4 receptor antagonist with oral antiinflammatory activityR A Daines, P A Chambers, J J Foley, et al.
Molecular Pharmacology|August 23, 2000
Evidence that the proposed novel human "neurokinin-4" receptor is pharmacologically similar to the human neurokinin-3 receptor but is not of human originH M Sarau, J L Mooney, D B Schmidt, et al.
Journal of Medicinal Chemistry|September 30, 1994
(E)-3-[[[[6-(2-carboxyethenyl)-5-[[8-(4- methoxyphenyl)octyl]oxy]-2-pyridinyl]-methyl]thio]methyl]benzoic acid and related compounds: high affinity leukotriene B4 receptor antagonistsR A Daines, P A Chambers, D S Eggleston, et al.
Nano Letters|December 15, 2016
Ultraconfined Plasmonic Hotspots Inside Graphene NanobubblesZ Fei, J J Foley, W Gannett, et al.
Journal of Medicinal Chemistry|September 3, 1993
(E)-3-[[[[6-(2-carboxyethenyl)-5-[[8-(4- methoxyphenyl)octyl]oxy]-2-pyridinyl]-methyl]thio]methyl]benzoic acid: a novel high-affinity leukotriene B4 receptor antagonistR A Daines, P A Chambers, I Pendrak, et al.
The Journal of Biological Chemistry|August 23, 1996
Molecular cloning and characterization of the human anaphylatoxin C3a receptorR S Ames, Y Li, H M Sarau, et al.
Molecular and Chemical Neuropathology|January 1, 1995
Time-related changes in myeloperoxidase activity and leukotriene B4 receptor binding reflect leukocyte influx in cerebral focal strokeF C Barone, L M Hillegass, M N Tzimas, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 2, 1998
Human anaphylatoxin C4a is a potent agonist of the guinea pig but not the human C3a receptorS Lienenklaus, R S Ames, M A Tornetta, et al.
Journal of Medicinal Chemistry|June 7, 1996
2-Phenyl-4-quinolinecarboxamides: a novel class of potent and selective non-peptide competitive antagonists for the human neurokinin-3 receptorG A Giardina, H M Sarau, C Farina, et al.
Pageof 7